Burning Rock Biotech Ltd (BNR)
Burning Rock Biotech Limited (NASDAQ:BNR) Q1 2024 Earnings Call Transcript May 29, 2024 Operator: Good day and thank you for standing by. Burning Rock Biotech Limited (NASDAQ:BNR) Q3 2023 Earnings ...
Model output · Signal date 2026-10-16
Burning Rock Biotech Ltd (BNR) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · Nasdaq
Rating · 90D
▲ Bullish
Exact rating locked
90-day forecast
Sign up free to reveal
30-day forecast
Total
Rank in coverage
Top 35%
of 5184 stocks scored
Rank correlation · 90D
5.0%
Spearman, 357 dates
Market Cap
$139M
small-cap · #20 of 29 peers
Summary
Burning Rock Biotech Ltd (BNR) stock forecast summary
Our AI ranks Burning Rock Biotech Ltd outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Burning Rock Biotech Ltd is a small-cap company with a market capitalization of $139M. It ranks number 20 by market capitalization among the 29 Services-Medical Laboratories issuers in our coverage with a current forecast.
For BNR, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 5.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 12.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.1%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, BNR included.
Follow BNR freePrice
BNR price chart and AI forecast
Cross-section · 2026-10-16
How BNR ranks among 5184 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Fundamentals · 2020-12-31
Burning Rock Biotech Ltd (BNR) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Medical Laboratories peers listed below that report each metric. Statement values were filed in CNY and are shown converted to USD (flows at the trailing twelve-month average rate, balances at the balance-sheet date rate).
Valuation & Market
| Metric | BNR | Rank |
|---|---|---|
| Market Cap | $139M | 20/29 |
| P/B Ratio | 2.44x | 12/22 |
| Book Value/Share | $5.28 | – |
Financial Health
| Metric | BNR | Rank |
|---|---|---|
| D/E Ratio | 0.10x | 19/22 |
| Financial Leverage | 1.10x | 19/22 |
| Interest Coverage | -619.7x | 19/23 |
Dividend & Shareholder Information
| Metric | BNR | Rank |
|---|---|---|
| Shares Outstanding | 11M | – |
Balance Sheet Highlights (USD millions, converted from CNY)
| Total Liabilities | $6M | 9.1% of assets |
Quarterly Financial Reports
BNR quarterly financials and insider trading
Industry Peers · Services-Medical Laboratories
Burning Rock Biotech Ltd (BNR) industry peers
Companies classified under the same SEC industry code as Burning Rock Biotech Ltd (Services-Medical Laboratories): 30 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| BNR Burning Rock Biotech Ltd | ▲ | $139M |
| NTRA Natera, Inc. | ▲ | $56.71B |
| DGX Quest Diagnostics Inc | ▼ | $25.94B |
| LH Labcorp Holdings Inc. | ▼ | $25.79B |
| GH Guardant Health, Inc. | ▲ | $21.28B |
| CAI Caris Life Sciences, Inc. | ▲ | $8.64B |
| RDNT Radnet, Inc. | ▶ | $5.41B |
| GRAL Grail, Inc. | ▲ | $5.26B |
| BLLN Billiontoone, Inc. | ▲ | $4.63B |
| VCYT Veracyte, Inc. | ▲ | $3.47B |
| CDNA Caredx, Inc. | ▲ | $3.31B |
| CELC Celcuity Inc. | ▲ | $2.77B |
| FTRE Fortrea Holdings Inc. | ▲ | $2.14B |
| PSNL Personalis, Inc. | ▲ | $1.67B |
| FRNM Freenome, Inc. | ▶ | $1.26B |
| LMRI Lumexa Imaging Holdings, Inc. | ▶ | $1.04B |
| CSTL Castle Biosciences Inc | ▲ | $976M |
| FLGT Fulgent Genetics, Inc. | ▲ | $545M |
| BDSX Biodesix Inc | ▲ | $250M |
| XGN Exagen Inc. | ▲ | $187M |
| SERA Sera Prognostics, Inc. | ▼ | $80M |
| CFOR Capforce Inc. | ▲ | $43M |
| MDXH Mdxhealth Sa | ▲ | $20M |
| AMS American Shared Hospital Services | ▼ | $9M |
| ADVB Advanced Biomed Inc. | ▼ | $7M |
| ACON Aclarion, Inc. | ▲ | $5M |
| BGLC Bionexus Gene Lab Corp | ▲ | $4M |
| LUDG Ludwig Enterprises, Inc. | ▼ | $670K |
| FCHS First Choice Healthcare Solutions, Inc. | ▼ | $260K |
| RNLXY Renalytix Plc | ▶ | N/A |
Where BNR sits on the market map
Industrial Applications and Services · Services-Medical Laboratories
News
Burning Rock Biotech Ltd (BNR) stock news
Sinking Burning Rock Faces De-Listing. But Could Privatization Bid Come First?
Burning Rock announced its shares could be delisted due to prolonged trading below the required $1 threshold The cancer detection specialist’s former biggest revenue source tumbled 40.6% in the third ...
Burning Rock Biotech : OncoCompass Target CDx Kit Enters NMPA Priority Approval Procedure
GUANGZHOU, China, October 10, 2026 - Burning Rock Biotech Limited ("Burning Rock") announced that its OncoCompass® Target CDx Kit has entered the National Medical Products Administration (NMPA) ...
FAQ
Burning Rock Biotech Ltd (BNR) stock forecast FAQ
What is the Burning Rock Biotech Ltd (BNR) stock forecast?
Our AI ranks Burning Rock Biotech Ltd outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Burning Rock Biotech Ltd stock predictions?
For BNR, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 5.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 12.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Burning Rock Biotech Ltd forecasts updated?
Burning Rock Biotech Ltd forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Burning Rock Biotech Ltd's industry peers?
30 issuers in our coverage, BNR included, share the SEC industry code Services-Medical Laboratories. The largest are: Natera, Inc. (NTRA), Quest Diagnostics Inc (DGX), Labcorp Holdings Inc. (LH), Guardant Health, Inc. (GH), Caris Life Sciences, Inc. (CAI), Radnet, Inc. (RDNT).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.